Proudly Canadian
Proudly Canadian Mounjaro is a once-weekly injection that targets GLP-1 and GIP hormones to reduce appetite, improve blood sugar control, and promote significant weight loss.
It’s approved for type 2 diabetes and often used off-label for weight management.
Unlimited doctor follow ups
Prescription delivery to your pharmacy
Personalized treatment plan
Convenient treatment options
Affordable pricing with no hidden fees
Unlimited doctor follow ups
Prescription delivery to your pharmacy
Personalized treatment plan
Convenient treatment options
Affordable pricing with no hidden fees
Mounjaro contains the same active ingredient as Zepbound (tirzepatide) but is Health Canada–approved for type 2 diabetes, not as a standalone weight loss treatment. However, significant weight loss is a well-documented effect, and it is sometimes prescribed off-label for weight management.
Mounjaro mimics the GLP-1 hormone, which slows the passage of food through the stomach, helping people feel fuller longer, and promotes insulin release to help reduce blood sugar. As a dual GLP-1/GIP agonist, it works on two hunger-signalling hormones simultaneously.
Starting at 2.5 mg once weekly for the first 4 weeks, then increased to 5 mg, and may be increased up to 15 mg once weekly if needed.
"Antlia is designed to support meaningful change through careful guidance, not quick promises. Their team made me feel seen from day one."
"Antlia is designed to support meaningful change through careful guidance, not quick promises. Their team made me feel seen from day one."
"Antlia is designed to support meaningful change through careful guidance, not quick promises. Their team made me feel seen from day one."
"Antlia is designed to support meaningful change through careful guidance, not quick promises. Their team made me feel seen from day one."
